Critical Outcome Technologies Appoints Alison Silva as Chief Executive Officer
December 08, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - December 08, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company"), a clinical stage biopharmaceutical company advancing a...
Critical Outcome Technologies Awards Stock Options
October 17, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON and BOSTON, MA--(Marketwired - October 17, 2016) - Critical Outcome Technologies Inc. ("COTI" or the "Company") (TSX VENTURE: COT) (OTCQB: COTQF), announced today that 1,691,427 stock...
Critical Outcome Technologies Provides Update on Recent Achievements and Future Strategic Objectives at Annual General Meeting
October 14, 2016 08:46 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON and BOSTON, MA--(Marketwired - October 14, 2016) - Critical Outcome Technologies Inc. ("COTI" or the "Company") (TSX VENTURE: COT) (OTCQB: COTQF), announced today that its Chief Executive...
Critical Outcome Technologies Announces Next Clinical Candidate, COTI-219, Targeting KRAS
October 11, 2016 09:21 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON and BOSTON, MA--(Marketwired - October 11, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company") a clinical-stage biopharmaceutical company...
Critical Outcome Technologies Reports Fiscal 2017 First Quarter Financial and Operating Results
September 29, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON and BOSTON, MA--(Marketwired - September 29, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company") reported its financial and operating...
Critical Outcome Appoints Dr. Bharatt Chowrira to Its Board of Directors
September 13, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - September 13, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company") a clinical-stage biopharmaceutical company advancing...
Critical Outcome Technologies Announces the Opening of Its U.S. Headquarters
August 23, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON, and BOSTON, MA--(Marketwired - August 23, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT)(OTCQB: COTQF) ("COTI" or the "Company") a clinical-stage biopharmaceutical company...
Critical Outcome Technologies Reports Year-End Financial & Operating Results
August 03, 2016 07:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - August 03, 2016) - Critical Outcome Technologies Inc. ("COTI" or the "Company") (TSX VENTURE: COT) (OTCQB: COTQF), a clinical-stage biopharmaceutical company advancing...
Critical Outcome Initiates Third Cohort in Phase 1 Study of COTI-2 in Gynecologic Cancers
July 12, 2016 09:17 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - July 12, 2016) - Critical Outcome Technologies Inc. ("COTI" or the "Company") (TSX VENTURE: COT) (OTCQB: COTQF), announced today that the Company has commenced dosing...
Critical Outcome Technologies Awards Stock Options
July 06, 2016 08:30 ET
|
Critical Outcome Technologies Inc. (COTI)
LONDON, ON--(Marketwired - July 06, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company") announced today that 3,000,000 stock options were awarded...